Sec-Butylamine → HCID 178448909, compound

HRID 1066160Notes

Reaction equation

N1([C:6]2[NH:11][C:10]3[CH:12]=[CH:13][C:14]([C:16]([OH:18])=[O:17])=[CH:15][C:9]=3[S:8](=[O:20])(=[O:19])[N:7]=2)C=CN=C1.[CH:21]([NH2:25])([CH2:23][CH3:24])[CH3:22]>>[CH:21]([NH:25][C:6]1[NH:11][C:10]2[CH:12]=[CH:13][C:14]([C:16]([OH:18])=[O:17])=[CH:15][C:9]=2[S:8](=[O:20])(=[O:19])[N:7]=1)([CH2:23][CH3:24])[CH3:22]

Participants

Reactant 2

HCID 24874Sec-Butylamine

HCID 11358291HCID 11358291, compound

Product 1

HCID 178448909HCID 178448909, compound

Procedure

3-(Imidazol-1-yl)-4H-1,2,4-benzothiadiazine-7-carboxylic acid 1,1-dioxide was treated with sec-butylamine according to the general procedure Method A to give the title compound; m.p. >310° C.

Sources & evidence

ORD record: ord-95e01544dcfd438d81a89a59331b2aaa
Source dataset: uspto-grants-2001_06
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US06242443B1

Reaction notes

Loading…